ArticleAmerican journal of ophthalmology case reports2023

Twelve-year outcome of Rho-associated protein kinase inhibitor eye drop treatment for Fuchs endothelial corneal dystrophy: A case study.

Yasufumi Tomioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.